1.9(top 20%)
impact factor
4.5K(top 5%)
papers
57.6K(top 5%)
citations
72(top 10%)
h-index
2.0(top 20%)
impact factor
4.8K
all documents
60.8K
doc citations
120(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011Modern Rheumatology20121,294
2Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011Modern Rheumatology2012947
3A novel clinical entity, IgG4-related disease (IgG4RD): general concept and detailsModern Rheumatology2012662
4A novel clinical entity, IgG4-related disease (IgG4RD): general concept and detailsModern Rheumatology2012453
5Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapyModern Rheumatology2009312
6A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic diseaseModern Rheumatology2006283
7Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patientsModern Rheumatology2016281
8Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validityModern Rheumatology2004256
9Risk of malignancies in IgG4-related diseaseModern Rheumatology2012244
10Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapyModern Rheumatology2009228
11Control of chondrogenesis by the transcription factor Sox9Modern Rheumatology2008223
12The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RDModern Rheumatology2021219
13A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic diseaseModern Rheumatology2006208
14Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteriaModern Rheumatology2017175
15Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung diseaseModern Rheumatology2013170
16Risk of malignancies in IgG4-related diseaseModern Rheumatology2012162
17Control of chondrogenesis by the transcription factor Sox9Modern Rheumatology2008161
18Quality of life and self-reported disability in patients with knee osteoarthritisModern Rheumatology2014149
19IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive reviewModern Rheumatology2019134
20Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritisModern Rheumatology2007130
21Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensionsModern Rheumatology2010127
22Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)Modern Rheumatology2014124
23Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trialModern Rheumatology2009114
24Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseasesModern Rheumatology2012111
25Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 studyModern Rheumatology2015109
26Epidemiology of nontraumatic osteonecrosis of the femoral head in JapanModern Rheumatology2015109
27A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosusModern Rheumatology2007107
28Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiationModern Rheumatology2013107
29Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensionsModern Rheumatology2010107
30Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year periodModern Rheumatology2008105
31Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) studyModern Rheumatology2014105
32Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE studyModern Rheumatology2008104
33Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING studyModern Rheumatology2009104
34Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritisModern Rheumatology2019104
35Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patientsModern Rheumatology2011103
36Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugsModern Rheumatology2011103
37Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patientsModern Rheumatology2014100
38Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseasesModern Rheumatology200998
39A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumabModern Rheumatology201297
40Cartilage destruction by matrix degradation productsModern Rheumatology200696
41Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter studyModern Rheumatology200996
42Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritisModern Rheumatology201996
43Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritisModern Rheumatology201195
44Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndromeModern Rheumatology201195
45Epidemiology of the locomotive syndrome: The research on osteoarthritis/osteoporosis against disability study 2005–2015Modern Rheumatology201793
46Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritisModern Rheumatology200792
47A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosusModern Rheumatology200792
48Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: Results from the SMART databaseModern Rheumatology201591
49Autoimmune-associated hemophagocytic syndromeModern Rheumatology200490
50Treatment of retinal vasculitis in Behçet's disease with rituximabModern Rheumatology200890